Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Kindred Biosciences, Inc. (KIN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/30/2021 |
4
| Chin Richard (CEO) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Disposed/sold 1,709,271 shares
@ $9.25, valued at
$15.8M
Disposed/sold 2,000 shares
@ $9.25, valued at
$18.5k
Disposed/sold 400,000 options to buy
@ $0.36, valued at
$144k
Disposed/sold 350,000 options to buy
@ $16.52, valued at
$5.8M
Disposed/sold 197,771 options to buy
@ $6.46, valued at
$1.3M
Disposed/sold 197,771 options to buy
@ $3.45, valued at
$682.3k
Disposed/sold 175,000 options to buy
@ $6.4, valued at
$1.1M
Disposed/sold 175,000 options to buy
@ $8.75, valued at
$1.5M
Disposed/sold 400,000 options to buy
@ $9.91, valued at
$4M
Disposed/sold 300,000 options to buy
@ $9.84, valued at
$3M
Disposed/sold 394,000 options to buy
@ $4.44, valued at
$1.7M
|
|
| 08/30/2021 |
4
| Wee Wendy (CFO) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Disposed/sold 78,613 shares
@ $9.25, valued at
$727.2k
Disposed/sold 32,500 options to buy
@ $6.96, valued at
$226.2k
Disposed/sold 10,000 options to buy
@ $3.25, valued at
$32.5k
Disposed/sold 75,000 options to buy
@ $6.4, valued at
$480k
Disposed/sold 50,000 options to buy
@ $7.1, valued at
$355k
Disposed/sold 75,000 options to buy
@ $8.75, valued at
$656.3k
Disposed/sold 100,000 options to buy
@ $9.91, valued at
$991k
Disposed/sold 50,000 options to buy
@ $9.84, valued at
$492k
Disposed/sold 83,500 options to buy
@ $4.44, valued at
$370.7k
|
|
| 08/30/2021 |
4
| Bevers Denise (Director) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Disposed/sold 145,835 shares
@ $9.25, valued at
$1.3M
Disposed/sold 20,400 options to buy
@ $0.9, valued at
$18.4k
Disposed/sold 96,092 options to buy
@ $1.37, valued at
$131.6k
Disposed/sold 75,000 options to buy
@ $15.41, valued at
$1.2M
Disposed/sold 59,031 options to buy
@ $6.96, valued at
$410.9k
Disposed/sold 59,031 options to buy
@ $3.45, valued at
$203.7k
Disposed/sold 30,000 options to buy
@ $3.6, valued at
$108k
Disposed/sold 100,000 options to buy
@ $6.4, valued at
$640k
Disposed/sold 100,000 options to buy
@ $8.75, valued at
$875k
Disposed/sold 75,000 options to buy
@ $12.6, valued at
$945k
Disposed/sold 150,000 options to buy
@ $9.91, valued at
$1.5M
|
|
| 08/30/2021 |
4
| Zhan Hangjun (Chief Scientific Officer) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Disposed/sold 64,306 shares
@ $9.25, valued at
$594.8k
Disposed/sold 12,000 options to buy
@ $19.96, valued at
$239.5k
Disposed/sold 7,500 options to buy
@ $9.17, valued at
$68.8k
Disposed/sold 8,000 options to buy
@ $6.96, valued at
$55.7k
Disposed/sold 10,000 options to buy
@ $3.25, valued at
$32.5k
Disposed/sold 15,000 options to buy
@ $3.6, valued at
$54k
Disposed/sold 75,000 options to buy
@ $6.4, valued at
$480k
Disposed/sold 50,000 options to buy
@ $7.65, valued at
$382.5k
Disposed/sold 80,000 options to buy
@ $8.75, valued at
$700k
Disposed/sold 100,000 options to buy
@ $9.91, valued at
$991k
Disposed/sold 50,000 options to buy
@ $9.84, valued at
$492k
|
|
| 08/30/2021 |
4
| Veszpremi Ervin (Director) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Disposed/sold 40,000 options to buy
@ $0.32, valued at
$12.8k
Disposed/sold 20,000 options to buy
@ $1.37, valued at
$27.4k
Disposed/sold 35,000 options to buy
@ $15.41, valued at
$539.4k
Disposed/sold 44,000 options to buy
@ $6.96, valued at
$306.2k
Disposed/sold 44,000 options to buy
@ $3.45, valued at
$151.8k
Disposed/sold 49,900 options to buy
@ $6.4, valued at
$319.4k
Disposed/sold 75,000 options to buy
@ $8.75, valued at
$656.3k
Disposed/sold 50,000 options to buy
@ $9.91, valued at
$495.5k
Disposed/sold 50,000 options to buy
@ $9.84, valued at
$492k
Disposed/sold 50,000 options to buy
@ $4.44, valued at
$222k
|
|
| 08/30/2021 |
4
| Townsend Raymond (Director) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Disposed/sold 24,928 shares
@ $9.25, valued at
$230.6k
Disposed/sold 20,000 options to buy
@ $7, valued at
$140k
Disposed/sold 34,000 options to buy
@ $15.41, valued at
$523.9k
Disposed/sold 44,000 options to buy
@ $6.96, valued at
$306.2k
Disposed/sold 18,892 options to buy
@ $3.45, valued at
$65.2k
Disposed/sold 49,900 options to buy
@ $6.4, valued at
$319.4k
Disposed/sold 75,000 options to buy
@ $8.75, valued at
$656.3k
Disposed/sold 50,000 options to buy
@ $9.91, valued at
$495.5k
Disposed/sold 50,000 options to buy
@ $9.84, valued at
$492k
Disposed/sold 50,000 options to buy
@ $4.44, valued at
$222k
|
|
| 08/30/2021 |
4
| MONTGOMERY HERBERT D (Director) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Disposed/sold 27,500 options to buy
@ $3.52, valued at
$96.8k
Disposed/sold 3,350 options to buy
@ $4.14, valued at
$13.9k
Disposed/sold 49,900 options to buy
@ $6.4, valued at
$319.4k
Disposed/sold 75,000 options to buy
@ $8.75, valued at
$656.3k
Disposed/sold 51,500 options to buy
@ $9.91, valued at
$510.4k
Disposed/sold 51,500 options to buy
@ $9.84, valued at
$506.8k
Disposed/sold 51,500 options to buy
@ $4.44, valued at
$228.7k
|
|
| 08/30/2021 |
4
| McCracken Joseph S (Director) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Disposed/sold 41,890 options to buy
@ $9.65, valued at
$404.2k
Disposed/sold 10,000 options to buy
@ $11, valued at
$110k
Disposed/sold 48,500 options to buy
@ $9.91, valued at
$480.6k
Disposed/sold 48,500 options to buy
@ $9.84, valued at
$477.2k
Disposed/sold 48,500 options to buy
@ $4.44, valued at
$215.3k
|
|
| 08/30/2021 |
4
| Lien Lyndon (Director) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Disposed/sold 47,000 options to buy
@ $5.08, valued at
$238.8k
|
|
| 08/30/2021 |
4
| Liu Nanxi (Director) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Disposed/sold 48,000 options to buy
@ $5.08, valued at
$243.8k
|
|
| 08/30/2021 |
4
| Elanco Animal Health Inc (10% Owner) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Bought 45,508,938 shares
@ $9.25, valued at
$421M
|
|
| 08/04/2021 |
4
| Chin Richard (CEO) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Gifted 320,000 shares
@ $0
Sold 40,000 shares
@ $9.206, valued at
$368.2k
|
|
| 07/07/2021 |
4
| Chin Richard (CEO) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Sold 40,000 shares
@ $9.177, valued at
$367.1k
|
|
| 06/25/2021 |
3
| Elanco Animal Health Inc (10% Owner) has filed a Form 3 on Kindred Biosciences, Inc. |
| 06/17/2021 |
4
| Chin Richard (CEO) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Sold 40,000 shares
@ $9.1817, valued at
$367.3k
|
|
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2021 |
4
| Bevers Denise (Director) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Sold 8,396 shares
@ $5.002, valued at
$42k
Exercised 8,396 options to buy
@ $0.32, valued at
$2.7k
|
|
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/09/2021 |
3/A
| Liu Nanxi (Director) has filed a Form 3/A on Kindred Biosciences, Inc. |
| 02/09/2021 |
4/A
| Liu Nanxi (Director) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Granted 48,000 options to buy
@ $5.08, valued at
$243.8k
|
|
| 02/09/2021 |
4
| Liu Nanxi (Director) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Granted 48,000 options to buy
@ $5.08, valued at
$243.8k
|
|
| 02/09/2021 |
3
| Liu Nanxi (Director) has filed a Form 3 on Kindred Biosciences, Inc. |
| 02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
4
| Park West Asset Management LLC (10% Owner) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Sold 210,472 shares
@ $5.25, valued at
$1.1M
Sold 3,300 shares
@ $5.07, valued at
$16.7k
|
|
| 01/26/2021 |
4
| Wee Wendy (CFO) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 4,062 shares
@ $4.93, valued at
$20k
Paid exercise price by delivering 3,385 shares
@ $4.93, valued at
$16.7k
Exercised 7,500 restricted stock units
@ $0 |
|
| 01/26/2021 |
4
| Zhan Hangjun (Chief Scientific Officer) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 3,385 shares
@ $4.93, valued at
$16.7k
Paid exercise price by delivering 3,385 shares
@ $4.93, valued at
$16.7k
Exercised 6,250 restricted stock units
@ $0 |
|
| 01/26/2021 |
4
| Chin Richard (CEO) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 19,744 shares
@ $4.93, valued at
$97.3k
Paid exercise price by delivering 13,163 shares
@ $4.93, valued at
$64.9k
Exercised 37,500 restricted stock units
@ $0 |
|
| 01/22/2021 |
4
| Veszpremi Ervin (Director) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Granted 50,000 options to buy
@ $4.44, valued at
$222k
|
|
| 01/22/2021 |
4
| McCracken Joseph S (Director) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Granted 48,500 options to buy
@ $4.44, valued at
$215.3k
|
|
| 01/22/2021 |
4
| MARIO ERNEST (Director) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Granted 49,000 options to buy
@ $4.44, valued at
$217.6k
|
|
| 01/22/2021 |
4
| Townsend Raymond (Director) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Granted 50,000 options to buy
@ $4.44, valued at
$222k
|
|
|
|
|